1α,25-Dihydroxyvitamin D 3 and Its Potent Synthetic Analogs Downregulate Tissue Factor and Upregulate Thrombomodulin Expression in Monocytic Cells, Counteracting the Effects of Tumor Necrosis Factor and Oxidized LDL
- 5 December 2000
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 102 (23), 2867-2872
- https://doi.org/10.1161/01.cir.102.23.2867
Abstract
Background —We have recently found that a hormonally active form of vitamin D, 1α,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], exerts anticoagulant effects by upregulating the expression of an anticoagulant glycoprotein, thrombomodulin (TM), and downregulating the expression of a critical coagulation factor, tissue factor (TF), in monocytic cells including human peripheral monocytes. In this study, we investigated the counteracting effects of 1,25(OH) 2 D 3 and its potent analogs on TF induction and TM downregulation by tumor necrosis factor and oxidized LDL in monocytic cells and the modulatory effects of potent analogs on TF and TM expression. Methods and Results —Effects of 1,25(OH) 2 D 3 and its potent synthetic analogs (22R)-22-methyl-20-epi-1,25(OH) 2 D 3 (KY3) and 22-oxacalcitriol on TF and TM antigen levels, cell surface activities, and mRNA levels in monocytic cells were examined. 1,25(OH) 2 D 3 and its potent analogs showed anticoagulant effects in monocytic cells by downregulating TF and upregulating TM expression, counteracting the effects of tumor necrosis factor and oxidized LDL. KY3 was most potent in its regulatory effect on TF and TM expression. Conclusions —Because KY3 has the highest affinity for vitamin D receptor, our findings suggest that TF and TM regulation by 1,25(OH) 2 D 3 analogs is also mediated by vitamin D receptor. The 1,25(OH) 2 D 3 analogs KY3 and 22-oxacalcitriol may have the potential to serve as an agent for preventing and treating atherosclerotic and other cytokine-mediated thrombotic diseases and as a tool for studying the molecular mechanisms of TF and TM regulation.Keywords
This publication has 16 references indexed in Scilit:
- Three-dimensional structure-function relationship of vitamin D: Side chain location and various activitiesBioorganic & Medicinal Chemistry Letters, 1999
- Role of Tissue Factor in Metastasis: Functions of the Cytoplasmic and Extracellular Domains of the MoleculeThrombosis and Haemostasis, 1999
- Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.JCI Insight, 1998
- Regulation of the Tissue Factor GeneThrombosis and Haemostasis, 1997
- Oxidized Low Density Lipoprotein Reduces Thrombomodulin Transcription in Cultured Human Endothelial Cells through Degradation of the Lipoprotein in LysosomesPublished by Elsevier BV ,1996
- Conformationally Restricted Analogs of 1α,25-Dihydroxyvitamin D3 and Its 20-Epimer: Compounds for Study of the Three-Dimensional Structure of Vitamin D Responsible for Binding to the ReceptorJournal of Medicinal Chemistry, 1996
- Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinomaHepatology, 1995
- All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cellsBlood, 1994
- Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factorBlood, 1992
- Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemiaFEBS Letters, 1987